Effect of
10.13703/j.0255-2930.20200925-0001
- Author:
Hong-Kui KE
1
;
Shao-Heng TU
1
;
Yu-Jie SHEN
1
;
Qun-Wei QU
1
Author Information
1. Department of Pain, Wuhan Puren Hospital, Wuhan 430081, Hubei Province, China.
- Publication Type:Randomized Controlled Trial
- Keywords:
5-hydroxytryptamine (5-HT);
ZHU Lian's type Ⅱ inhibition acupuncture;
acupuncture therapy;
calcitonin gene-related peptide (CGRP);
chronic migraine;
vascular endothelial growth factor (VEGF)
- MeSH:
Acupuncture Therapy;
Calcitonin;
Calcitonin Gene-Related Peptide;
Humans;
Migraine Disorders/therapy*;
Quality of Life;
Serotonin;
Vascular Endothelial Growth Factor A;
Vascular Endothelial Growth Factors
- From:
Chinese Acupuncture & Moxibustion
2021;41(10):1079-1083
- CountryChina
- Language:Chinese